Enhancement of monensin titers by either pZC32
plasmid-based expression of mutAB or addition of exogenous
dl-valine. A, meaA mutant (WM2); B, WM2/pZC32;
C, meaA icm mutant (WD2); D, WD2/pZC32; E, WD2 cells grown
in the presence of 0.1 M dl-valine; F, WD2 cells grown with
0.8 M dl-valine.